Source comparison
TB-500 Dosage Protocol: Research Application Comparison
The table below compares three common TB-500 dosage protocols used in published research, detailing their pharmacokinetic profiles, typical applications, and practical trade-offs. Loading-Maintenance 10mg twice weekly × 4 weeks, then 5mg once weekly × 8 weeks
This comparison does not assign a generated winner or score.
- The table below compares three common TB-500 dosage protocols used in published research, detailing their pharmacokinetic profiles, typical applications, and practical trade-offs.
- Loading-Maintenance
- 10mg twice weekly × 4 weeks, then 5mg once weekly × 8 weeks
- 10–14 days
- Acute injury models, wound healing, vascular repair studies
- 120mg total peptide
- Fastest measurable outcomes; front-loads cost but accelerates data collection timeline
- Continuous Fixed-Dose
- 5mg once weekly × 12 weeks
- 4–6 weeks
- Mechanistic studies, dose-response curves, chronic inflammation models
- 60mg total peptide
- Most predictable plasma concentration curve; slower onset but lower total peptide consumption
- Cyclical Dosing
- 5mg twice weekly × 4 weeks, 2-week washout, repeat cycle
- Resets each cycle
- Receptor desensitization studies, transient exposure experiments
- 80mg total peptide
- Ideal for comparing acute vs chronic effects; washout complicates tissue repair applications